Evidence map›Paper›PMID 37111253›Full record

ReviewPharmaceuticals (Basel, Switzerland)2023

The Relevance and Insights on 1,4-Naphthoquinones as Antimicrobial and Antitumoral Molecules: A Systematic Review.

Gabriela Navarro-Tovar, Sarai Vega-Rodríguez, Elisa Leyva, Silvia Loredo-Carrillo, Denisse de Loera, Lluvia Itzel López-López

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Design,ACS omega · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Gabriela Navarro-TovarFacultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, San Luís Potosí 78210, Mexico.ORCID 0000-0003-3789-2324
Sarai Vega-RodríguezFacultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, San Luís Potosí 78210, Mexico.ORCID 0000-0002-9434-9515
Elisa LeyvaFacultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, San Luís Potosí 78210, Mexico.
Silvia Loredo-CarrilloFacultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, San Luís Potosí 78210, Mexico.
Denisse de LoeraFacultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, San Luís Potosí 78210, Mexico.ORCID 0000-0002-5291-2197
Lluvia Itzel López-LópezInstituto de Investigación de Zonas Desérticas, Universidad Autónoma de San Luis Potosí, San Luís Potosí 78377, Mexico.ORCID 0000-0002-6408-3306
Autonomous University of San Luis Potosí · MX

Funding

Universidad Autónoma de San Luis Potosí FAI-2020
6 · The paper itself

Abstract

Natural product derivatives are essential in searching for compounds with important chemical, biological, and medical applications. Naphthoquinones are secondary metabolites found in plants and are used in traditional medicine to treat diverse human diseases. Considering this, the synthesis of naphthoquinone derivatives has been explored to contain compounds with potential biological activity. It has been reported that the chemical modification of naphthoquinones improves their pharmacological properties by introducing amines, amino acids, furan, pyran, pyrazole, triazole, indole, among other chemical groups. In this systematic review, we summarized the preparation of nitrogen naphthoquinones derivatives and discussed their biological effect associated with redox properties and other mechanisms. Preclinical evaluation of antibacterial and/or antitumoral naphthoquinones derivatives is included because cancer is a worldwide health problem, and there is a lack of effective drugs against multidrug-resistant bacteria. The information presented herein indicates that naphthoquinone derivatives could be considered for further studies to provide drugs efficient in treating cancer and multidrug-resistant bacteria.

Indexed as

antimicrobialantitumoralbioactive secondary metabolitesnaphthoquinones

Identifiers

PMID37111253
PMCPMC10144089
OpenAlexW4361223849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.